Expression of fibrinolysis activators and their inhibitor in neointima of polyester vascular grafts

Biomaterials

Volumn 25, Issue 28, 2004, Pages 5987-5993

  Kowalewski, Radoslaw ^a   Zimnoch, Lech ^a   Wojtukiewicz, Marek Z ^a   Glowinski, Jerzy ^a   Glowinski, Stanislaw ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Endothelium; Haemostasis; Immunochemistry; Tissue plasminogen activator; Vascular grafts

Indexed keywords

GRAFTS; IMPLANTS (SURGICAL); POLYESTERS; PROSTHETICS; TISSUE;

FIBRINOLYSIS ACTIVATORS; THROMBOTIC PROPERTIES; VASCULAR GRAFTS;

BIOMATERIALS;

D DIMER; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYESTER; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR; VON WILLEBRAND FACTOR;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL GRAFT; DOG; FEMALE; FIBRINOLYSIS; IMMUNOHISTOCHEMISTRY; INTIMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS; STAINING; SUBSTITUTION THERAPY; THROMBOSIS;

BLOOD VESSEL PROSTHESIS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYESTERS; RECEPTORS, CELL SURFACE; TUNICA INTIMA;

CANIS FAMILIARIS; RICKETTSIA SP. PAR;

EID: 2942574716     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2004.02.008     Document Type: Article

References (39)

1. Madras P.N., Johnson W.R., Ward C.A. Enhancement of thrombus formation by vascular prostheses. Can J Surg. 23:1980;544-546
2. Ascer E., Veith F.J., White-Flores S.A., Morin L., Gupta S.K., Lesser M.L. Intraoperative outflow resistance as a predictor of late patency of femoropopliteal and infrapopliteal arterial bypasses. J Vasc Surg. 5:1987;820-827
3. Stewart G.J., Essa N., Chang K.H.Y., Reichle F.A. A scanning and transmission electron microscope study of the luminal coating on Dacron prostheses in the canine thoracic aorta. J Lab Clin Med. 85:1975;208-226
4. Earnshaw J.J., Westby J.C., Makin G.S., Hopkinson B.R. Defective fibrinolysis. a risk factor in early femoropopliteal graft thrombosis Br J Surg. 74:1987;932-935
5. Glowinski S., Worowski K. The haemostatic system components of neointima forming in polyester aortic grafts in the early postoperative period. Haematologia. 14:1981;393-398
6. Sato O., Tada Y., Takagi A. The biologic fate of Dacron double velour vascular prostheses-a clinicopathological study. Jpn J Surg. 3:1989;301-311
7. Shi Q., Wu M.H.D., Hayashida N., Wechazek A.R., Clowes A.W., Sauvage L.R. Proof of fallout endothelialization of impervious Dacron grafts in the aorta and inferior vena cava of the dog. J Vasc Surg. 20:1994;546-557
8. Wu M.H-.D., Shi Q., Kouchi Y., Onuki Y., Ghali R., Yoshida H., et al. Implant site influence on arterial prosthesis healing. a comparative study with a triple implantation model in the same dog J Vasc Surg. 25:1997;528-536
9. Levin E.G., Loskutoff D.J. Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators. J Cell Biol. 94:1982;631-636
10. Mignatti P., Rifkin D.B. Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein. 49:1996;117-137
11. Collen D., Stassen J.M., Stump D.C., Verstraete M. Synergism of thrombolytic agents in vivo. Circulation. 74:1986;838-842
12. Sprengers E.D., Kluft C. Plasminogen activator inhibitors. Blood. 69:1987;381-387
13. Handt S., Jerome W.G., Tietze L., Hantgan R.R. Plasminogen activator inhibitor-1 secretion by endothelial cells increases fibrinolytic resistance of an in vitro fibrin clot. evidence for a key role of endothelial cells in thrombolytic resistance Blood. 87:1996;4204-4213
14. Ellis V., Behrendt N., Danø K. Plasminogen activation by receptor bound urokinase. a kinetic study with both cell-associated and isolated receptor J Biol Chem. 266:1991;12752-12758
15. Kroon M.E., Koolwijk P., van der Vecht B., van Hinsberg V.W.M. Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia. implications for capillary-like tube formation in a fibrin matrix Blood. 96:2000;2775-2783
16. Gosselin R.C., Owings J.T., Utter G.H., Jacoby R.C., Larkin E.C. A new method for measuring D-dimer using immunoturbidometry. a study of 255 patients with suspected pulmonary embolism and deep vein thrombosis Blood Coagul Fibrinolysis. 11:2000;715-721
17. Yao J.S., Bergan J.J., Kwaan H.C. Quantification of fibrinolytic activity in venous and prosthetic arterial grafts. Arch Surg. 109:1974;163-167
18. Glowinski S., Worowski K. Distribution and variation of thromboplastic and fibrinolytic activity of dacron aortic grafts. Cor Vasa. 21:1979;296-303
19. Sulkin M.D., Gervin A.S. Fibrinolytic activity in pseudointima of dacron aortic grafts. Am Surg. 40:1974;675-679
20. Harvey R.A., Kim H.C., Pincus J., Trooskin S.Z., Wilcox J.N., Greco R.S. Binding of tissue plasminogen activator to vascular grafts. Thromb Haemost. 61:1989;131-136
21. Kitamoto Y., Tomita M., Kiyama S., Inoue T., Yabushita Y., Sato T., et al. Antithrombotic mechanisms of urokinase immobilized polyurethane. Thromb Haemost. 65:1991;73-76
22. Sasajima T., Takano Y., Hiraishi Y., Goh K., Inaba M., Azuma N., et al. High accumulation of plasminogen and tissue plasminogen activator at the flow surface of mural fibrin in the human arterial system. J Vasc Surg. 32:2000;374-382
23. Arnman V., Nilsson A., Stemme S., Risberg B., Rymo L. Expression of plasminogen activator inhibitor-1 mRNA in healthy, artherosclerotic and thrombotic human arteries and veins. Thromb Res. 76:1994;487-499
24. Peltonen S., Lassila R., Lepäntalo M. Increased circulating plasminogen activator inhibitor-1 in patients with patent femorodistal venous bypass. Thromb Res. 82:1996;262-267
25. Kauhanen P., Siren V., Carpen O., Vaheri A., Lepantalo M., Lassila R. Plasminogen activator inhibitor-1 in neointima of vein grafts. its role in reduced fibrinolytic potential and graft failure Circulation. 96:1997;1783-1789
26. Yates S.G., Barros D'Sa A.A., Berger K., Fernandez L.G., Wood S.J., Rittenhouse E.A., et al. The preclotting of porous arterial prostheses. Ann Surg. 188:1978;611-622
27. Sato Y., Mukai K., Watanabe S., Goto M., Shimosato Y. The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol. 125:1986;431-435
28. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. a comparison between ABC and unlabeled antibody (PAP) procedures J Hist Cytochem. 29:1981;577-580
29. Britton J.P., Leveson S.H. Distal arterial bypass by composite grafting. Br J Surg. 74:1987;249-251
30. Woodburn K.R., Rumley A., Lowe G.D., Love J.G., Murray G.D., Pollock J.G. Clinical, biochemical, and rheologic factors affecting the outcome of infrainguinal bypass grafting. J Vasc Surg. 24:1996;639-646
31. Wu M.H-.D., Kouchi Y., Onuki Y., Shi Q., Yoshida H., Kaplan S., et al. Effect of differential shear stress on platelet aggregation, surface thrombosis, and endothelialization of bilateral carotid-femoral grafts in the dog. J Vasc Surg. 22:1995;382-392
32. Dilly R., Herring M., Boxer L., Gardner A., Glover J. Immunofluorescent staining for factor VIII related antigen. a tool for study of healing in vascular prostheses J Surg Res. 27:1979;149-155
33. Sirén V., Kauhanen P., Carpén O., Luther M., Lepäntalo M., Vaheri A., et al. Urokinase, tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in severely stenosed and occluded vein grafts with thrombosis. Blood Coagul Fibrinolysis. 14:2003;369-377
34. Clowes A.W., Clowes M.M., Au Y.P., Reidy M.A., Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 67:1990;61-67
35. Quax P.H.A., Pedersen N., Masucci M.T., Weening-Verhoeff E.J.D., Danø K., Verheijnen J.H., et al. Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation. Cell Regulation. 2:1991;793-803
36. Lemson S.M., Tordoir J.H.M., Daemen M.J.A.P., Kitslaar P.J.E.H.M. Intimal hyperplasia in vascular grafts. Eur J Vasc Surg. 19:2000;336-351
37. Carmeliet P., Collen D. Molecular analysis of blood vessel formation and disease. Am J Physiol. 273:1997;H2091-H2104
38. Urayama H., Katada S., Kasashima F., Tanaka Y., Kawasuji M., Watanabe Y. Rupture of pseudointima in an implanted vascular prosthesis. immunohistological study of plasminogen activators and matrix metalloproteinases J Cardiovasc Surg. 41:2000;459-462
39. Xiaoli M., Wenying H., Mingpeng S. Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation. Int J Cardiol. 66(Suppl 1):1998;S57-S64